National Health Investors (NYSE:NHI) Updates FY24 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $4.37-4-43 for the period, compared to the consensus earnings per share estimate of $4.35.

National Health Investors Trading Down 0.0 %

National Health Investors stock traded down $0.01 during mid-day trading on Wednesday, reaching $65.64. 187,871 shares of the company traded hands, compared to its average volume of 171,536. National Health Investors has a 52-week low of $48.51 and a 52-week high of $66.10. The company has a debt-to-equity ratio of 0.90, a current ratio of 10.27 and a quick ratio of 10.27. The firm’s 50 day moving average price is $60.81 and its 200 day moving average price is $56.48. The firm has a market capitalization of $2.85 billion, a price-to-earnings ratio of 20.97 and a beta of 0.95.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 2nd. Shareholders of record on Friday, June 28th will be issued a dividend of $0.90 per share. The ex-dividend date is Friday, June 28th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.48%. National Health Investors’s dividend payout ratio (DPR) is 115.02%.

Wall Street Analyst Weigh In

NHI has been the topic of a number of research reports. BMO Capital Markets upgraded shares of National Health Investors from a market perform rating to an outperform rating and set a $67.00 target price on the stock in a report on Tuesday, March 12th. Wells Fargo & Company raised National Health Investors from an equal weight rating to an overweight rating and lifted their price target for the stock from $55.00 to $63.00 in a research report on Monday, February 26th. Wedbush upped their target price on shares of National Health Investors from $64.00 to $66.00 and gave the stock an outperform rating in a research note on Monday, March 18th. StockNews.com cut shares of National Health Investors from a buy rating to a hold rating in a research note on Thursday, April 18th. Finally, Deutsche Bank Aktiengesellschaft began coverage on shares of National Health Investors in a report on Tuesday, January 30th. They set a buy rating and a $69.00 price objective for the company. Five analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of Hold and an average target price of $60.50.

Insiders Place Their Bets

In other news, Director Charlotte A. Swafford bought 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 27th. The stock was bought at an average price of $58.69 per share, with a total value of $586,900.00. Following the acquisition, the director now owns 110,185 shares of the company’s stock, valued at approximately $6,466,757.65. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 8.21% of the stock is owned by company insiders.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.